Current Roles

Employees:
11
Revenue:
$1.7M
About
Ridgeback Biotherapeutics is a biotechnology company focused on developing treatments and diagnostics for underserved patient populations primarily in pediatric orphan and emerging infectious diseases. The team at Ridgeback is dedicated to working toward finding life-saving and life changing solutions for patients and diseases that need champions. Headquartered in Miami, Florida, Ridgeback Biotherapeutics is a privately held, majority woman-owned biotechnology company; all funding for Ridgeback Biotherapeutics has originated from Wayne and Wendy Holman; two science driven individuals who invest in technologies that they believe will make the world a better place.
Ridgeback Biotherapeutics Address
3480 Main Hwy
Miami, FL
Ridgeback Biotherapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.